UW Cardiovascular Pathology Training Program
(This web site is best viewed using Internet Explorer or Mozilla - some symbols and tables do not translate well when viewed using Netscape)

Summer Course Reading References

The complex interplay among factors that influence allelic association ( Jarvik)

The Pathophysiology and Treatment of Sepsis (Wed. Pulmonary vascular disease)

Critically Ill patients with Severe Acute Respiratory Syndrome (Wed. Pulmonary vascular disease)

CD95’s deadly mission in the immune system (Wed. Pulmonary vascular disease)

The Acute Respiratory Distress Syndrome (Wed. Pulmonary vascular disease)

The role of apoptosis in acute lung injury (Wed. Pulmonary vascular disease)

Fas (CD95) Induces Alveolar Epithelial Cell Apoptosis in Vivo (Wed. Pulmonary vascular disease)

Soluble Fas Ligand Induces Epithelial Cell Apoptosis in Humans with Acute Lung Injury (ARDS) (Wed. Pulmonary vascular disease)

Ventilator-associated lung injury (Wed. Pulmonary vascular disease)

Diabetes as a Vascular Disease (Contact Karin Bornfeldt directly bornf@u.washington.edu)

Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy (Harlan)

T-Cell Function and Migration (Harlan)

Cell–cell interactions: leukocyte–endothelial interactions (Harlan)

Tumorigenesis and the angiogenic switch (Disis)

Antiangiogenic therapy and tumor progression (Disis)

Angiogenesis in Health and Disease (Disis)

Vasculogenic Mimicry and Tumor Angiogenesis (Disis)

The promise of cancer vaccines (Disis)

Vasculogenic Mimicry and Tumour-Cell Plasticity: Lessons from Melanoma (Disis)

Molecular regulation of vessel maturation (Disis)

Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Disis)

Active Immunization against the Vascular Endothelial Growth Factor Receptor flk1 Inhibits Tumor Angiogenesis and Metastasis (Disis)

Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine (Disis)

Imaging of angiogenesis: from microscope to clinic (Disis)

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth (Disis)

Vessel maneuvers: Vaccine targets tumor vasculature (Disis)

Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2 (Disis)

Molecular basis of angiogenesis and cancer (Disis)

Microvessel Density as a Prognostic Factor in Women with Breast Cancer: A Systematic Review of the Literature and Meta-Analysis (Disis)

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine (Disis)

Stem Cells Basic Primer (LaFlamme)

Endothelial Progenitor Cells: New Hope for a Broken Heart (LaFlamme)

The role of stem cells for treatment of cardiovascular disease (LaFlamme)

Interventional Approaches to the Introduction of Genetic Material into the Cardiovascular System (Dichek)

Collateralization and the response to obstruction of epicardial coronary arteries (Simons – Monday)

Re-evaluating therapeutic neovascularization (Simons – Monday)

Factors regulating arteriogenesis (Simons – Monday)

Therapeutic angiogenesis in cardiovascular disease (Simons – Monday)

Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms (Simons – Monday)

CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization (Simons – Monday)

Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2 (Simons – Monday)

Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor (Simons – Monday)

Bone marrow-derived cells do not incorporate into the adult growing vasculature (Simons – Monday)

Novel angiogenic signaling pathways and vascular targets (Simons – Thursday)

Blood vessels and nerves: common signals, pathways and diseases (Simons – Thursday)

The biology of VEGF and its receptors (Simons – Thursday)

VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism (Simons – Thursday)

Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway (Simons – Thursday)

Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha (Simons – Thursday)

ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA (Simons – Thursday)

Fibroblast growth factor-specific modulation of cellular response by syndecan-4 (Simons – Thursday)

Syndecan-4-mediated signaling (Simons – Thursday)